NPASS Compound

Natural Product: NPC575904

Natural Product ID	NPC575904
Common Name ? The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.	(14R,15R)-14-ethenyl-5-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene
IUPAC Name	(13~{R},17~{R})-3-methoxy-13-methyl-17-vinyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene
Synonyms
Synthetic Gene Cluster	n.a.
ChEMBL Identifier	n.a.
PubChem CID	n.a.
Chemical Classification	CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

Chemical Representations

RDKit 3D 50 53 0 0 0 0 0 0 0 0999 V2000 -5.4558 -0.6647 -0.5430 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.5814 -0.5243 0.4363 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3757 0.2965 0.2140 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.2333 1.3547 1.3010 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8165 1.8263 1.0700 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0484 0.5736 0.6470 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3103 0.9157 -0.6203 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6393 2.0692 -0.3794 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7087 1.7091 0.6270 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4055 0.5022 0.0991 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7193 0.3103 0.5045 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4343 -0.7731 0.0669 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7589 -0.9696 0.4736 O 0 0 0 0 0 0 0 0 0 0 0 0 6.3712 -0.0442 1.3449 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8294 -1.6694 -0.7819 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5243 -1.4702 -1.1789 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7948 -0.3846 -0.7457 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3954 -0.2520 -1.2259 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3403 -1.5607 -0.9996 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8065 -1.2593 -0.8562 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0899 -0.4776 0.3852 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.1934 -1.3905 1.5821 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.3679 -1.2575 -0.4455 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.3113 -0.1920 -1.5082 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.7322 -0.9967 1.3910 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.3682 0.7601 -0.7850 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.9693 2.1414 1.0700 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.3785 0.8778 2.2858 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.4158 2.2566 1.9863 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.8693 2.5648 0.2293 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.3258 0.2599 1.4370 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0714 1.3037 -1.3578 H 0 0 0 0 0 0 0 0 0 0 0 0 1.1262 2.2858 -1.3631 H 0 0 0 0 0 0 0 0 0 0 0 0 0.1070 2.9739 -0.0698 H 0 0 0 0 0 0 0 0 0 0 0 0 1.2531 1.5466 1.6065 H 0 0 0 0 0 0 0 0 0 0 0 0 2.4014 2.5688 0.6989 H 0 0 0 0 0 0 0 0 0 0 0 0 4.2053 1.0142 1.1755 H 0 0 0 0 0 0 0 0 0 0 0 0 7.4187 -0.3751 1.5210 H 0 0 0 0 0 0 0 0 0 0 0 0 6.3982 0.9771 0.8683 H 0 0 0 0 0 0 0 0 0 0 0 0 5.8628 0.0059 2.3258 H 0 0 0 0 0 0 0 0 0 0 0 0 4.3785 -2.5269 -1.1351 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0935 -2.1965 -1.8425 H 0 0 0 0 0 0 0 0 0 0 0 0 0.4334 -0.0773 -2.3332 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.2011 -2.2797 -1.8134 H 0 0 0 0 0 0 0 0 0 0 0 0 0.0280 -2.0288 -0.0562 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.4129 -2.1977 -0.8554 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.1367 -0.6642 -1.7339 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.2381 -1.9743 1.6251 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.2177 -0.7858 2.5019 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.0195 -2.1014 1.4807 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 2 0 11 12 1 0 12 13 1 0 13 14 1 0 12 15 2 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 1 21 3 1 0 21 6 1 0 18 7 1 0 17 10 1 0 1 23 1 0 1 24 1 0 2 25 1 0 3 26 1 6 4 27 1 0 4 28 1 0 5 29 1 0 5 30 1 0 6 31 1 0 7 32 1 0 8 33 1 0 8 34 1 0 9 35 1 0 9 36 1 0 11 37 1 0 14 38 1 0 14 39 1 0 14 40 1 0 15 41 1 0 16 42 1 0 18 43 1 0 19 44 1 0 19 45 1 0 20 46 1 0 20 47 1 0 22 48 1 0 22 49 1 0 22 50 1 0 M END

Standard InCHIKey	FMOXSNJSHYESRI-CAPGZYGZSA-N
Standard InCHI	InChI=1S/C21H28O/c1-4-15-6-10-20-19-8-5-14-13-16(22-3)7-9-17(14)18(19)11-12-21(15,20)2/h4,7,9,13,15,18-20H,1,5-6,8,10-12H2,2-3H3/t15-,18?,19?,20?,21+/m0/s1
SMILES	C=C[C@H]1CCC2C3CCC4=CC(OC)=CC=C4C3CC[C@@]21C

Calculated Properties

Physi-Chem Properties

Molecular Weight:	296.21	Volume:	335.791 ? Van der Waals volume.
Dense:	0.882	LogP:	5.896 ? The logarithm of the n-octanol/water distribution coefficients.
logD7.4:	4.328 ? The logarithm of the n-octanol/water distribution coefficient at pH=7.4.	LogS:	-6.826 ? The logarithm of aqueous solubility value.
Rotatable Bonds:	2.0	Rigid Bonds:	21.0
TPSA:	9.23 ? Topological Polar Surface Area.	H-Bond Acceptor:	1.0
H-Bond Donor:	0.0	Rings:	4.0
Heavy Atoms:	1.0

MedChem Properties

QED Drug-Likeness Score:	0.668	GASA:	1.0 ? GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:	3.69	Fsp³:	0.619
MCE-18:	80.235 ? MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.	Lipinski Rule-of-5:	Rejected
Pfizer Rule:	Accepted	GSK Rule:	Accepted
Golden Triangle Rule:	Rejected	BMS Rule:	0
Chelating Alert:	0	PAINS Alert:	0
Colloidal aggregators:	0.705	Fluc inhibitor:	0.347 ? The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:	0.014 ? The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1	Green fluorescence:	0.006 ? The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:	0.519	Promiscuous compounds:	0.054

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:	-4.564	MDCK Permeability:	-4.71
Pgp-inhibitor:	0.966	Pgp-substrate:	0.005
PAMPA:	0.0 ? The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).	Human Intestinal Absorption (HIA):	0.001
20% Bioavailability (F20%):	0.351	30% Bioavailability (F30%):	0.579
50% Bioavailability (F50%):	0.9

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.823	MRP1:	0.778
Plasma Protein Binding (PPB):	98.409%	Volume Distribution (VD):	0.603
Fu:	1.18% ? The fraction unbound in plasms.	OATP1B1 inhibitor:	0.898
OATP1B3 inhibitor:	0.953	BCRP inhibitor:	0.926
BSEP inhibitor:	0.977

ADMET: Metabolism

CYP1A2-inhibitor:	0.999	CYP1A2-substrate:	0.534
CYP2C19-inhibitor:	1.0	CYP2C19-substrate:	0.033
CYP2C9-inhibitor:	1.0	CYP2C9-substrate:	0.107
CYP2D6-inhibitor:	1.0	CYP2D6-substrate:	0.229
CYP3A4-inhibitor:	0.153	CYP3A4-substrate:	0.148
CYP2B6-substrate:	1.0	CYP2C8-inhibitor:	0.999
HLM stability:	0.978 ? Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):

10.176

Half-life (T1/2):

0.474

ADMET: Toxicity

hERG Blockers:	0.397	hERG Blockers (10um):	0.817
Human Hepatotoxicity (H-HT):	0.524	Drug-induced Liver Injury (DILI):	0.59
AMES Toxicity:	0.262	Rat Oral Acute Toxicity:	0.275
Maximum Recommended Daily Dose:	0.94	Skin Sensitization:	0.085
Carcinogencity:	0.914	Eye Corrosion:	0.019
Eye Irritation:	0.723	Respiratory Toxicity:	0.967
Drug-induced Neurotoxicity:	0.587	Ototoxicity:	0.515
Hematotoxicity:	0.15	Drug-induced Nephrotoxicity:	0.082
Genotoxicity:	0.017	RPMI-8226 Immunitoxicity:	0.038
A549 Cytotoxicity:	0.454	Hek293 Cytotoxicity:	0.813
BCF:	2.996 ? Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].	IGC50:	4.882 ? 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:	5.77 ? 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].	LC50FM:	5.78 ? 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO62342	Scleronephthya gracillimum	Species	Nephtheidae	Eukaryota	n.a.	n.a.	n.a.	Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	Organism Name	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Molecular-level activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vitro activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vivo activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

Experimental ADME

Experiment Model	Experiment Tissue	ADME Type	ADME Relation	ADME Value	ADME Unit	Reference

Experimental Toxicity

Quantitative toxicity

Experiment Model	Experiment Organism	Toxicity Type	Toxicity Relation	Toxicity Value	Toxicity Unit	Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity	Carcinogenicity	Mutagenicity	Cardiotoxicity	Respiratory Toxicity	Eye Irritation	Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]

Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

● The left chart: Distribution of similarity level between NPC575904 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	12554
0.1-0.2	35448
0.2-0.3	1816
0.3-0.4	30
0.4-0.5	8
0.5-0.6	0
0.6-0.7	2
0.7-0.8	0
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	1

Similarity Score	Similarity Level	Natural Product ID
1.0	High Similarity	NPC33900
0.6812	Remote Similarity	NPC485507
0.6438	Remote Similarity	NPC95990

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC575904 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	3277
0.1-0.2	5618
0.2-0.3	223
0.3-0.4	12
0.4-0.5	14
0.5-0.6	2
0.6-0.7	1
0.7-0.8	0
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
0.6154	Remote Similarity	NPD4624	Phase 4
0.5672	Remote Similarity	NPD5327	Phase 3
0.5522	Remote Similarity	NPD4140	Phase 4

Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data